Male germ cell tumors.
New treatment approaches to male germ cell tumors have produced dramatic improvements in both survival and cure rates. The traditional use of surgery and radiation therapy for all male germ cell neoplasms has given way to individualized therapy based on histology, stage and the serum tumor markers. Cure rates of 95 percent for seminomas and 80 percent for nonseminomatous germ cell tumors are now achieved.
D000328:Adult; D002822:Choriocarcinoma / Q000628:therapy*; D004407:Dysgerminoma / Q000628:therapy*; D006801:Humans; D007248:Infertility, Male / Q000209:etiology; D008297:Male; D008649:Mesonephroma / Q000628:therapy*; D009367:Neoplasm Staging; D013724:Teratoma / Q000628:therapy*; D013736:Testicular Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy*